Wire · opportunities
FDA clears iHealthScreen's AI diabetic retinopathy screening software
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 10 July 2026 · Fusion42 review
iHealthScreen received FDA clearance for iPredict-DR, an AI-based software that detects diabetic retinopathy from retinal images captured by widely-used iCare DRSplus cameras in optometry clinics. The company plans to pursue additional clearances for AMD, glaucoma, hypertensive retinopathy, and cardiovascular disease screening.
This Wire brief sits within Fusion42's coverage of Digital Health.
◆ ◆ The Wire takeaway
If you build AI for eye imaging or disease detection from retinal scans, you now have a live FDA pathway and a competitor with cleared software. iHealthScreen has de-risked the regulatory route and proven the hardware (iCare cameras) will work with AI software — that's your market definition and your go-to-market route.
◆ Coverage
1 source · 10 Jul 2026
◆ Related on Wire
◆ Topics